Skip to main content
SpringerLink
Log in

The Canonical and Unconventional Ligands of the Herpesvirus Entry Mediator

  • Conference paper
  • First Online:
Advances in TNF Family Research

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 691))

Abstract

The maintenance of immune homeostasis requires a balance between stimulatory and inhibitory pathways. The herpesvirus entry mediator (HVEM; TNFRSF14) [1] serves as one of two key entry routes used by herpes simplex virus-1 and herpes simplex virus-2 to infect cells [2].

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Montgomery RI, Warner MS, Lum B, Spear PG (1996) Herpes simplex virus 1 entry into cells mediated by a novel member of the TNF/NGF receptor family. Cell 87:427–436

    Article  CAS  PubMed  Google Scholar 

  2. Taylor JM, Lin E, Susmarski N, Yoon M, Zago A, Ware CF, Pfeffer K, Miyoshi J, Takai Y, Spear PG (2007) Alternative entry receptors for herpes simplex virus and their roles in disease. Cell Host Microbe 2:19–28

    Article  CAS  PubMed  Google Scholar 

  3. Kaye J (2008) CD160 and BTLA: LIGHTs out for CD4+ T cells. Nat Immunol 9:122–124

    Article  CAS  PubMed  Google Scholar 

  4. Murphy KM, Nelson AC, Sedy JR (2006) Balancing co-stimulation and inhibition with BTLA and HVENat M. Rev Immunol 6:671–681

    CAS  Google Scholar 

  5. De Trez C, Schneider K, Potter K, Droin N, Fulton J, Norris PS, Ha SW, Fu YX, Murphy T, Murphy KM, Pfeffer K, Benedict CA, Ware CF (2008) The inhibitory HVEM-BTLA pathway counter regulates lymphotoxin receptor signaling to achieve homeostasis of dendritic cells. J Immunol 180:238–248

    PubMed  Google Scholar 

  6. Steinberg MW, Turovskaya O, Shaikh RB, Kim G, McCole DF, Pfeffer K, Murphy KM, Ware CF, Kronenberg M (2008) A crucial role for HVEM and BTLA in preventing intestinal inflammation. J Exp Med 205:1463–1476

    Article  CAS  PubMed  Google Scholar 

  7. Mauri DN, Ebner R, Montgomery RI, Kochel KD, Cheung TC, Yu GL, Ruben S, Murphy M, Eisenberg RJ, Cohen GH, Spear PG, Ware CF (1998) LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator. Immunity 8:21–30

    Article  CAS  PubMed  Google Scholar 

  8. Cheung TC, Steinberg MW, Oborne LM, Macauley MG, Fukuyama S, Sanjo H, D’Souza C, Norris PS, Pfeffer K, Murphy KM, Kronenberg M, Spear PG, Ware CF (2009) Unconventional ligand activation of herpesvirus entry mediator signals cell survival. Proc Natl Acad Sci U S A 106:6244–6249

    Article  CAS  PubMed  Google Scholar 

  9. Ware CF (2008) Targeting lymphocyte activation through the lymphotoxin and LIGHT pathways. Immunol Rev 223:186–201

    Article  CAS  PubMed  Google Scholar 

  10. Pennica D, Nedwin GE, Hayflick JS, Seeburg PH, Derynck R, Palladino MA, Kohr WJ, Aggarwal BB, Goeddel DV (1984) Human tumour necrosis factor: precursor structure, expression and homology to lymphotoxin. Nature 312:724–729

    Article  CAS  PubMed  Google Scholar 

  11. Granger SW, Butrovich KD, Houshmand P, Edwards WR, Ware CF (2001) Genomic Characterization of LIGHT reveals linkage to an immune response locus on chromosome 19p13.3 and distinct isoforms generated by alternate splicing or proteolysis. J Immunol 167:5122–5128

    CAS  PubMed  Google Scholar 

  12. Granger SW, Ware CF (2001) Commentary: turning on LIGHT. J Clin Invest 108:1741–1742

    CAS  PubMed  Google Scholar 

  13. Rooney IA, Butrovich KD, Glass AA, Borboroglu S, Benedict CA, Whitbeck JC, Cohen GH, Eisenberg RJ, Ware CF (2000) The lymphotoxin-beta receptor is necessary and sufficient for LIGHT-mediated apoptosis of tumor cells. Biol J (Chem) 275:14307–14315

    Article  CAS  Google Scholar 

  14. Harrop JA, McDonnell PC, Brigham-Burke M, Lyn SD, Minton J, Tan KB, Dede K, Spampanato J, Silverman C, Hensley P, DiPrinzio R, Emery JG, Deen K, Eichman C, Chabot-Fletcher M, Truneh A, Young PR (1998) Herpesvirus entry mediator ligand (HVEM-L), a novel ligand for HVEM/TR2, stimulates proliferation of T cells and inhibits HT29 cell growth. J Biol Chem 273:27548–27556

    Article  CAS  PubMed  Google Scholar 

  15. Bodmer JL, Schneider P, Tschopp J (2002) The molecular architecture of the TNF superfamily. Trends Biochem Sci 27:19–26

    Article  CAS  PubMed  Google Scholar 

  16. Cheung TC, Humphreys IR, Potter KG, Norris PS, Shumway HM, Tran BR, Patterson G, Jean-Jacques R, Yoon M, Spear PG, Murphy KM, Lurain NS, Benedict CA, Ware CF (2005) Evolutionarily divergent herpesviruses modulate T cell activation by targeting the herpesvirus entry mediator cosignaling pathway. Proc Natl Acad Sci U S A 102:13218–13223

    Article  CAS  PubMed  Google Scholar 

  17. Gonzalez LC, Loyet KM, Calemine-Fenaux J, Chauhan V, Wranik B, Ouyang W, Eaton DL (2005) A coreceptor interaction between the CD28 and TNF receptor family members B and T lymphocyte attenuator and herpesvirus entry mediator. Proc Natl Acad Sci U S A 102: 1116–1121

    Article  CAS  PubMed  Google Scholar 

  18. Zhai Y, Guo R, -Hsu LT, -Yu LG, Ni J, Kwon BS, Jiang G-w, Lu J, Tan J, Ugustus M, Carter K, Rojas L, Zhu F, Lincoln C, Endress G, Xing L, Wang S, -Oh OK, Gentz R, Ruben S, Lippman ME, -Hsieh LS, Yang D (1998) LIGHT, a novel ligand for lymphotoxin b receptor and TR2/HVEM induces apoptosis and suppresses in vivo tumor formation via gene transfer. J Clin Invest 102:1142–1151

    Article  CAS  PubMed  Google Scholar 

  19. Mortarini R, Scarito A, Nonaka D, Zanon M, Bersani I, Montaldi E, Pennacchioli E, Patuzzo R, Santinami M, Anichini A (2005) Constitutive expression and costimulatory function of LIGHT/TNFSF14 on human melanoma cells and melanoma-derived microvesicles. Cancer Res 65:3428–3436

    CAS  PubMed  Google Scholar 

  20. Sedy JR, Gavrieli M, Potter KG, Hurchla MA, Lindsley RC, Hildner K, Scheu S, Pfeffer K, Ware CF, Murphy TL, Murphy KM (2005) B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator. Nat Immunol 6:90–98

    Article  CAS  PubMed  Google Scholar 

  21. Cai G, Anumanthan A, Brown JA, Greenfield EA, Zhu B, Freeman GJ (2008) CD160 inhibits activation of human CD4+ T cells through interaction with herpesvirus entry mediator. Nat Immunol 9:176–185

    Article  CAS  PubMed  Google Scholar 

  22. Gavrieli M, Watanabe N, Loftin SK, Murphy TL, MurphyKM (2003) Characterization of phosphotyrosine binding motifs in the cytoplasmic domain of B and T lymphocyte attenuator required for association with protein tyrosine phosphatases SHP-1 and SHP-2. Biochem Biophys Res Commun 312:1236–1243

    Article  CAS  PubMed  Google Scholar 

  23. Chemnitz JM, Lanfranco AR, Braunstein I, Riley JL (2006) B and T lymphocyte attenuator-mediated signal transduction provides a potent inhibitory signal to primary human CD4 T cells that can be initiated by multiple phosphotyrosine motifs. J Immunol 176:6603–6614

    CAS  PubMed  Google Scholar 

  24. Gavrieli M, Murphy KM (2006) Association of Grb-2 and PI3K p85 with phosphotyrosile peptides derived from BTLBiochem A. Biophys Res Commun 345:1440–1445

    Article  CAS  Google Scholar 

  25. Han P, Goularte OD, Rufner K, Wilkinson B, Kaye J (2004) An inhibitory Ig superfamily protein expressed by lymphocytes and APCs is also an early marker of thymocyte positive selection. J Immunol 172:5931–5939

    CAS  PubMed  Google Scholar 

  26. Otsuki N, Kamimura Y, Hashiguchi M, Azuma M (2006) Expression and function of the B and T lymphocyte attenuator (BTLA/CD272) on human T cells. Biochem Biophys Res Commun 344:1121–1127

    Article  CAS  PubMed  Google Scholar 

  27. Le Bouteiller P, Barakonyi A, Giustiniani J, Lenfant F, Marie-Cardine A, Aguerre-Girr M, Rabot M, Hilgert I, Mami-Chouaib F, Tabiasco J, Boumsell L, Bensussan A (2002) Engagement of CD160 receptor by HLA-C is a triggering mechanism used by circulating natural killer (NK) cells to mediate cytotoxicity. Proc Natl Acad Sci U S A 99: 16963–16968

    Article  PubMed  Google Scholar 

  28. Giustiniani J, Marie-Cardine A, Bensussan A (2007) A soluble form of the MHC class I-specific CD160 receptor is released from human activated NK lymphocytes and inhibits cell-mediated cytotoxicity. J Immunol 178:1293–1300

    CAS  PubMed  Google Scholar 

  29. Giustiniani J, Bensussan A, Marie-Cardine A (2009) Identification and characterization of a transmembrane isoform of CD160 (CD160-TM), a unique activating receptor selectively expressed upon human NK cell activation. J Immunol 182:63–71

    CAS  PubMed  Google Scholar 

  30. Anumanthan A, Bensussan A, Boumsell L, Christ AD, Blumberg RS, Voss SD, Patel AT, Robertson MJ, Nadler LM, Freeman GJ (1998) Cloning of BY55, a novel Ig superfamily member expressed on NK cells, CTL, and intestinal intraepithelial lymphocytes. J Immunol 161:2780–2790

    CAS  PubMed  Google Scholar 

  31. Compaan DM, Gonzalez LC, Tom I, Loyet KM, Eaton D, Hymowitz SG (2005) Attenuating lymphocyte activity: the crystal structure of the BTLA-HVEM complex. J Biol Chem 280:39553–39561

    Article  CAS  PubMed  Google Scholar 

  32. Carfi A, Willis SH, Whitbeck JC, Krummenacher C, Cohen GH, Eisenberg RJ, Wiley DC (2001) Herpes simplex virus glycoprotein D bound to the human receptor HveA. Molecular Cell 8:169–179

    CAS  Google Scholar 

  33. Connolly SA, Landsburg DJ, Carfi A, Wiley DC, Eisenberg RJ, Cohen GH (2002) Structure-based analysis of the herpes simplex virus glycoprotein D binding site present on herpesvirus entry mediator HveA (HVEM). J Virol 76:10894–10904

    Article  CAS  PubMed  Google Scholar 

  34. Sarrias MR, Whitbeck JC, Rooney I, Ware CF, Eisenberg RJ, Cohen GH, Lambris JD (2000) The three HveA receptor ligands, gD, LT-alpha and LIGHT bind to distinct sites on HveMol A. Immunology 37:665–673

    CAS  Google Scholar 

  35. Krummenacher C, Supekar VM, Whitbeck JC, Lazear E, Connolly SA, Eisenberg RJ, Cohen GH, Wiley DC, Carfi A (2005) Structure of unliganded HSV gD reveals a mechanism for receptor-mediated activation of virus entry. EMBO J 24:4144–4153

    Article  CAS  PubMed  Google Scholar 

  36. Handler CG, Cohen GH, Eisenberg RJ (1996) Cross-linking of glycoprotein oligomers during herpes simplex virus type 1 entry. J Virol 70:6076–6082

    CAS  PubMed  Google Scholar 

  37. Benedict C, Butrovich K, Lurain N, Corbeil J, Rooney I, Schenider P, Tschopp J, Ware C (1999) Cutting edge: a novel viral TNF receptor superfamily member in virulent strains of human cytomegalovirus. Immunol J 162:6967–6970

    CAS  Google Scholar 

  38. Lurain NS, Kapell KS, Huang DD, Short AJ, Paintsil J, Winkfield E, Benedict WC, CA, Bremer WJ (1999) Human cytomegalovirus UL144 open reading frame: sequence hypervariability in low-passage clinical isolates. J Virol 73:10040–10050

    Google Scholar 

  39. Campadelli Fiume G, Arsenakis M, Farabegoli F, Roizman B (1988) Entry of herpes simplex virus 1 in BJ cells that constitutively express viral glycoprotein D is by endocytosis and results in degradation of the virus. J Virol 62:159–167

    CAS  PubMed  Google Scholar 

Download references

Acknowledgments

Support for this work was provided by grants from the National Institutes of Health (R37AI33068, AI067890, AI048073, and CA069381).

Author information

Authors and Affiliations

  1. Department of Neurosciences, University of California - San Diego, La Jolla, CA, 92093, USA

    Timothy C. Cheung

  2. Mycobacterial Research Division, Centenary Institute, Missenden Road, Camperdown, NSW 2050, Australia

    Timothy C. Cheung

  3. Division of Molecular Immunology, La Jolla Institute for Allergy and Immunology, 9420 Athena Circle, La Jolla, 92037, CA, USA

    Carl F. Ware

  4. Laboratory of Molecular Immunology, Sanford Burnham Medical Research Institute, 10901 N. Torrey Pines Road, La Jolla, CA, 92037, USA

    Carl F. Ware

Authors
  1. Timothy C. Cheung
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Carl F. Ware
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding authors

Correspondence to Timothy C. Cheung or Carl F. Ware .

Editor information

Editors and Affiliations

  1. Dept. Biological Chemistry, Weizmann Institute of Science, 1 Herzl Street, Rehovot, 76100, Israel

    David Wallach

  2. Dept. Biological Chemistry, Weizmann Institute of Science, 1 Herzl Street, Rehovot, 76100, Israel

    Andrew Kovalenko

  3. Kennedy Institute of Rheumatology, Imperial College London, Aspenlea Rd. 1, London, W6 8LH, United Kingdom

    Marc Feldmann

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this paper

Cite this paper

Cheung, T.C., Ware, C.F. (2011). The Canonical and Unconventional Ligands of the Herpesvirus Entry Mediator. In: Wallach, D., Kovalenko, A., Feldmann, M. (eds) Advances in TNF Family Research. Advances in Experimental Medicine and Biology, vol 691. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-6612-4_36

Download citation

Publish with us

Policies and ethics

Search

Navigation